Scientists Pinpoint New Drug Target for Devastating “Brain on Fire” Disease

A new study reveals a critical vulnerability in a brain receptor targeted by a rare autoimmune disease. Researchers have ...

OHSU researchers identify key trigger behind brain disorder often mistaken for mental illness

Some serious brain disorders begin with symptoms that are easy to misinterpret. A person may become confused, forgetful or ...
Hoodline

Portland Lab Nails the 'Brain on Fire' Culprit in Stunning Microscopic Detail

New OHSU study maps antibody "hot spots" behind anti‑NMDAR encephalitis. Could change diagnosis and treatment.

Rare 'Brain on Fire' disorder highlighted in Netflix film may soon have new treatments thanks to OHSU

No standard treatments for the sometimes deadly disorder have been developed, but that may change due to the newly published ...

Gilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major Depressive Disorder

Gilgamesh Pharma, a clinical-stage neuroscience company focused on transforming psychiatric treatment, today announced positive topline results from its Phase 2a study of blixeprodil (GM-1020).